REPORTS

Let’s Pullulate and Expand Your Business

Anthrax Vaccines Market - Global Professional Analysis and Forecast to 2026

Dec 24, 2019  |  136 PAGES  |  REPORT CODE: CMM257640
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Anthrax Vaccines market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.0% during the forecast period.

This report presents the market size and development trends by detailing the Anthrax Vaccines market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Anthrax Vaccines market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Anthrax Vaccines industry and will help you to build a panoramic view of the industrial development.

Anthrax Vaccines Market, By Type:

  • Live Vaccines

  • Cell free PA Vaccines

Anthrax Vaccines Market, By Application:

  • Human Use

  • Animal Use

Some of the leading players are as follows:

  • IVPM

  • Colorado Serum

  • Bayer Sanidad Animal

  • Merial

  • Tiankang

  • CDV

  • Emergent BioSolutions

  • Vecol

  • Merck

  • Agrovet

  • JOVAC

  • Zoetis

  • Rosenbusch

  • Botswana Vaccine Institute

  • PharmAthene

  • Prondil

  • CVCRI

  • Ceva Santé Animale

  • Intervac

  • Indian Immunologicals

  • Biogénesis-Bago

  • CAVAC

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Anthrax Vaccines Market: Technology Type Analysis

  • 4.1 Anthrax Vaccines Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Anthrax Vaccines Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Live Vaccines

    • 4.3.2 Cell free PA Vaccines

5 Anthrax Vaccines Market: Product Analysis

  • 5.1 Anthrax Vaccines Product Market Share Analysis, 2018 & 2026

  • 5.2 Anthrax Vaccines Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Anthrax Vaccines Market: Application Analysis

  • 6.1 Anthrax Vaccines Application Market Share Analysis, 2018 & 2026

  • 6.2 Anthrax Vaccines Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Human Use

    • 6.3.2 Animal Use

7 Anthrax Vaccines Market: Regional Analysis

  • 7.1 Anthrax Vaccines Regional Market Share Analysis, 2018 & 2026

  • 7.2 Anthrax Vaccines Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 IVPM

    • 9.1.1 IVPM Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Colorado Serum

    • 9.2.1 Colorado Serum Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Bayer Sanidad Animal

    • 9.3.1 Bayer Sanidad Animal Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Merial

    • 9.4.1 Merial Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Tiankang

    • 9.5.1 Tiankang Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 CDV

    • 9.6.1 CDV Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Emergent BioSolutions

    • 9.7.1 Emergent BioSolutions Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Vecol

    • 9.8.1 Vecol Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Merck

    • 9.9.1 Merck Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Agrovet

    • 9.10.1 Agrovet Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 JOVAC

    • 9.11.1 JOVAC Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

  • 9.12 Zoetis

    • 9.12.1 Zoetis Company overview

    • 9.12.2 Financial performance

    • 9.12.3 Product benchmarking

    • 9.12.4 Strategic initiatives

    • 9.12.5 SWOT analysis

  • 9.13 Rosenbusch

    • 9.13.1 Rosenbusch Company overview

    • 9.13.2 Financial performance

    • 9.13.3 Product benchmarking

    • 9.13.4 Strategic initiatives

    • 9.13.5 SWOT analysis

  • 9.14 Botswana Vaccine Institute

    • 9.14.1 Botswana Vaccine Institute Company overview

    • 9.14.2 Financial performance

    • 9.14.3 Product benchmarking

    • 9.14.4 Strategic initiatives

    • 9.14.5 SWOT analysis

  • 9.15 PharmAthene

    • 9.15.1 PharmAthene Company overview

    • 9.15.2 Financial performance

    • 9.15.3 Product benchmarking

    • 9.15.4 Strategic initiatives

    • 9.15.5 SWOT analysis

  • 9.16 Prondil

    • 9.16.1 Prondil Company overview

    • 9.16.2 Financial performance

    • 9.16.3 Product benchmarking

    • 9.16.4 Strategic initiatives

    • 9.16.5 SWOT analysis

  • 9.17 CVCRI

    • 9.17.1 CVCRI Company overview

    • 9.17.2 Financial performance

    • 9.17.3 Product benchmarking

    • 9.17.4 Strategic initiatives

    • 9.17.5 SWOT analysis

  • 9.18 Ceva Santé Animale

    • 9.18.1 Ceva Santé Animale Company overview

    • 9.18.2 Financial performance

    • 9.18.3 Product benchmarking

    • 9.18.4 Strategic initiatives

    • 9.18.5 SWOT analysis

  • 9.19 Intervac

    • 9.19.1 Intervac Company overview

    • 9.19.2 Financial performance

    • 9.19.3 Product benchmarking

    • 9.19.4 Strategic initiatives

    • 9.19.5 SWOT analysis

  • 9.20 Indian Immunologicals

    • 9.20.1 Indian Immunologicals Company overview

    • 9.20.2 Financial performance

    • 9.20.3 Product benchmarking

    • 9.20.4 Strategic initiatives

    • 9.20.5 SWOT analysis

  • 9.21 Biogénesis-Bago

    • 9.21.1 Biogénesis-Bago Company overview

    • 9.21.2 Financial performance

    • 9.21.3 Product benchmarking

    • 9.21.4 Strategic initiatives

    • 9.21.5 SWOT analysis

  • 9.22 CAVAC

    • 9.22.1 CAVAC Company overview

    • 9.22.2 Financial performance

    • 9.22.3 Product benchmarking

    • 9.22.4 Strategic initiatives

    • 9.22.5 SWOT analysis

 

The List of Tables and Figures (Totals 85 Figures and 155 Tables)

  • Figure Live Vaccines Anthrax Vaccines market, 2015 - 2026 (USD Million)

  • Figure Cell free PA Vaccines Anthrax Vaccines market, 2015 - 2026 (USD Million)

  • Figure Human Use market, 2015 - 2026 (USD Million)

  • Figure Animal Use market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Anthrax Vaccines market, by country, 2015 - 2026 (USD Million)

  • Table North America Anthrax Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table North America Anthrax Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table North America Anthrax Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Anthrax Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Anthrax Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Anthrax Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Anthrax Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Canada Anthrax Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Canada Anthrax Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Europe Anthrax Vaccines market, by country, 2015 - 2026 (USD Million)

  • Table Europe Anthrax Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Europe Anthrax Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Europe Anthrax Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Anthrax Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Anthrax Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Anthrax Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Anthrax Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Germany Anthrax Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Germany Anthrax Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Anthrax Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table France Anthrax Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table France Anthrax Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Anthrax Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Italy Anthrax Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Italy Anthrax Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Anthrax Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Spain Anthrax Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Spain Anthrax Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Anthrax Vaccines market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Anthrax Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Anthrax Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Anthrax Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Anthrax Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table China Anthrax Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table China Anthrax Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Anthrax Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Japan Anthrax Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Japan Anthrax Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Anthrax Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table India Anthrax Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table India Anthrax Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Anthrax Vaccines market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Anthrax Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Anthrax Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Anthrax Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Anthrax Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Anthrax Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Anthrax Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Anthrax Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Anthrax Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Anthrax Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Anthrax Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Anthrax Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Anthrax Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table MEA Anthrax Vaccines market, by country, 2015 - 2026 (USD Million)

  • Table MEA Anthrax Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table MEA Anthrax Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table MEA Anthrax Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Anthrax Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Anthrax Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Anthrax Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Anthrax Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Anthrax Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Anthrax Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table IVPM Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Colorado Serum Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Bayer Sanidad Animal Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Merial Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Tiankang Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table CDV Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Emergent BioSolutions Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Vecol Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Merck Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Agrovet Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table JOVAC Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Zoetis Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Rosenbusch Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Botswana Vaccine Institute Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table PharmAthene Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Prondil Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table CVCRI Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Ceva Santé Animale Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Intervac Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Indian Immunologicals Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Biogénesis-Bago Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table CAVAC Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top